Approved Foreign Follow-On Biologics / Biosimilars
Biosimilars Approved In Canada
Adheroza (trastuzumab) (Intas / Shanghai Henlius Biotech) (August-2024)
Biosimilars Approved In The E.U.
Zercepac (trastuzumab) (Shanghai Henlius Biotech / Accord Healthcare Ltd.) (July-2020)
Biosimilars Approved In Australia
Tuzucip® / Trastucip® (trastuzumab) (Shanghai Henlius Biotech / Cipla) (July-2022)
U.S. Patent Litigations
PERJETA / HLX112:25-cv-14648 (D.N.J.)PROLIA / XGEVA / HLX141:25-cv-12160 (D.N.J.)